1PVZ
Solution Structure of BmP07, A Novel Potassium Channel Blocker from Scorpion Buthus martensi Karsch, 15 structures
SOLUTION NMR
NMR Experiment | ||||||||
---|---|---|---|---|---|---|---|---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
1 | DQF-COSY | 2.7mM BmP07; 90% H2O, 10% D2O | 90% H2O/10% D2O | 3.0 | ambient | 300 | ||
2 | 2D NOESY | 2.7mM BmP07; 90% H2O, 10% D2O | 90% H2O/10% D2O | 3.0 | ambient | 300 | ||
3 | 2D TOCSY | 2.7mM BmP07; 90% H2O, 10% D2O | 90% H2O/10% D2O | 3.0 | ambient | 300 | ||
4 | DQF-COSY | 2.7mM BmP07; 100% D2O | 100% D2O | 3.0 | ambient | 300 | ||
5 | 2D NOESY | 2.7mM BmP07; 100% D2O | 100% D2O | 3.0 | ambient | 300 | ||
6 | 2D TOCSY | 2.7mM BmP07; 100% D2O | 100% D2O | 3.0 | ambient | 300 |
NMR Spectrometer Information | |||
---|---|---|---|
Spectrometer | Manufacturer | Model | Field Strength |
1 | Varian | INOVA | 600 |
NMR Refinement | ||
---|---|---|
Method | Details | Software |
distance geometry | the structures are based on a total of 277 constraints, 249 are NOE-derived distance constraints, 9 dihedral angle constraints, 19 distance constraints from five hydrogen bonds and three disulfide bonds. | VNMR |
NMR Ensemble Information | |
---|---|
Conformer Selection Criteria | structures with the lowest energy |
Conformers Calculated Total Number | 200 |
Conformers Submitted Total Number | 15 |
Representative Model | 1 (lowest energy) |
Additional NMR Experimental Information | |
---|---|
Details | This structure was determined using standard 2D homonuclear techniques. |
Computation: NMR Software | ||||
---|---|---|---|---|
# | Classification | Version | Software Name | Author |
1 | collection | VNMR | 6.1B | Mike Carlisle, Dan Steele, Mike Miller |
2 | processing | VNMR | 6.1B | Mike Carlisle, Dan Steele, Mike Miller |
3 | data analysis | XEASY | 1994 | Tai-he Xia, Christian Bartel |
4 | structure solution | DYANA | 1.5 | Peter Guntert, Christian Mumenthaler, Torsten Herrmann |
5 | refinement | Amber | 5.0 | Peter Kollman, Dave Case, Ken Merz, Thomas Cheatham, Carlos Simmerling, Vertex Pharmaceuticals |